In July 2001, GDS Technology was acquired by San Antonio, TX based Stanbio Laboratory. GDS Technology is a manufacturer of clinical chemistry reagents, enzymes, and the STAT-Site® multi-analyte dry-chemistry test system. business. GDS Technology manufactures microbial fermentation and purification of enzymes combined with research and development for biochemical and microbiological research. The company is actively engaged in seeking new enzymes for the development of diagnostic test systems. Mutation technology has been developed to provide higher yielding organisms. In addition to the marketing of diagnostic enzymes, GDS Technology performs contract research and contract production and purification of enzymes on projects of common interest. The fermentation facility at GDS Technology is designed to produce microorganisms, including recombinant organisms, from which commercially important enzymes and proteins are purified. These enzymes are either sold in bulk or used in the production of in vitro diagnostic devices (IVDs) manufactured according to cGMP and subject to 510(k) clearance by the FDA. The use of GDS' own enzymes provides high sensitivity and specificity along with the simplicity of enzyme test procedures. All liquid, two-reagent kits for acetaminophen, salicylate, theophylline, and Ã-hydroxybutyrate (blood ketone) are available for the professional laboratory market. Bulk liquid enzymatic reagents for OEM use are also offered. GDS is also currently engaged in the research/development, manufacturing and sale of diagnostic point-of-care testing for diabetes, neonatal and therapeutic drug monitoring and other critical disease states on a global basis. Their point-of-care STAT-Site® System combines several technologies: universal blood separation technology, proprietary enzyme technology and multi-wavelength reflectance photometric instrument technology. This portable, hand-held, multi-analyte system provides accurate and immediate, plasma equivalent results, from a drop of finger stick blood, leading to faster diagnosis and treatment for improved outcomes and reduced cost. GDS products offer diagnostic profiles for the management of diabetes, anemia, drugs and lipids. With the STAT-Site System, the clinician can now test for cholesterol, glucose, blood ketone, hemoglobin and acetaminophen from a drop of finger stick blood at the patientâs side, with one discrete, hand held analyzer.The GDS family of dry-chemistry tests can all be performed on one STAT-Site Analyzer, an importantimprovement over those systems which require a dedicated meter for each test. This translates into reduced equipment costs, maintenance and meter confusion while increasing ease of use and patient satisfaction ratings for the GDS custom
